HaugenBR, AlexanderEK, BibleKC, et al.2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016;26(1):1–133.
2.
ItoY, MiyauchiA, InoueH, et al.An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg, 2010;34(1):28–35.
3.
SugitaniI, TodaK, YamadaK, et al.Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: Our treatment strategies and outcomes. World J Surg, 2010;34(6):1222–1231.
4.
LeeEK, MoonJH, HwangboY, et al.Progression of low-risk papillary thyroid microcarcinoma during active surveillance: Interim analysis of a multicenter prospective cohort study of active surveillance on papillary thyroid microcarcinoma (MAeSTro) in Korea. Thyroid, 2022;32(11):1328–1336.
5.
TuttleRM, FaginJA, MinkowitzG, et al.Active surveillance of papillary thyroid cancer-frequency and time course of the 6 most common tumor volume kinetic patterns. Thyroid, 2022;32(11):1337–1345.
6.
HoAS, KimS, ZaltC, et al.Expanded parameters in active surveillance for low-risk papillary thyroid carcinoma: A nonrandomized controlled trial. JAMA Oncol, 2022:e223875; doi: 10.1001/jamaoncol.2022.3875
7.
MolinaroE, CampopianoMC, PieruzziL, et al.Active surveillance in papillary thyroid microcarcinomas is feasible and safe: Experience at a Single Italian Center. J Clin Endocrinol Metab, 2020;105(3):e172–e180.
8.
JinM, KimHI, HaJ, et al.Tumor volume doubling time in active surveillance of papillary thyroid microcarcinoma: A Multicenter Cohort Study in Korea. Thyroid, 2021;31(10):1494–1501.
9.
SakaiT, SugitaniI, EbinaA, et al.Active surveillance for T1bN0M0 papillary thyroid carcinoma. Thyroid, 2019;29(1):59–63.
10.
HoAS, DaskivichTJ, SacksWL, et al.Parallels between low-risk prostate cancer and thyroid cancer: A review. JAMA Oncol, 2019;5(4):556–564.
11.
PittSC, YangN, SauckeMC, et al.Adoption of active surveillance for very low-risk differentiated thyroid cancer in the United States: A national survey. J Clin Endocrinol Metab, 2021;106(4):e1728–e1737.
12.
SawkaAM, GhaiS, RotsteinL, et al.A quantitative analysis examining patients' choice of active surveillance or surgery for managing low-risk papillary thyroid cancer. Thyroid, 2022;32(3):255–262.
13.
HughesDT, Reyes-GastelumD, WardKC, et al.Barriers to the use of active surveillance for thyroid cancer results of a physician survey. Ann Surg, 2022;276(1):e40–e47.
14.
LimHK, ChoSJ, BaekJH, et al.US-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: Efficacy and safety in a large population. Korean J Radiol, 2019;20(12):1653–1661.
